NLRP3 and metabolic disease: Following the line, researchers proved that cholesterol crystals promote inflammation by activating the inflammasome pathway and this finding raised the horizon for other similar research that demonstrates the link between metabolic diseases like cardiometabolic syndrome and NLRP3 inflammasome biomarkers activation [5].